Enrollment on track in Phase 3 AURORA trial of Descartes-08 in myasthenia gravis IND application for Descartes-08 in myositis accepted by FDA; ...
Q2 2026 Earnings Call Transcript January 8, 2026 Neogen Corporation beats earnings expectations. Reported EPS is $0.1, ...
Learn how to create burndown charts to track project progress, improve team performance, and download free templates to get ...